BioCentury
ARTICLE | Clinical News

Oxycodone DETERx: Phase III data

August 11, 2014 7:00 AM UTC

Top-line data from a double-blind, U.S. Phase III trial in 389 opioid-experienced or opioid-naive patients with moderate to severe chronic low back pain showed that Oxycodone DETERx met the primary en...